|
IPO7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.703400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.722600E-01 |
| Normal-vs-Stage2 |
5.054800E-01 |
| Normal-vs-Stage3 |
3.529000E-01 |
| Normal-vs-Stage4 |
6.707400E-01 |
| Stage1-vs-Stage2 |
4.956400E-01 |
| Stage1-vs-Stage3 |
2.776800E-01 |
| Stage1-vs-Stage4 |
6.485200E-01 |
| Stage2-vs-Stage3 |
9.073000E-01 |
| Stage2-vs-Stage4 |
8.548800E-01 |
| Stage3-vs-Stage4 |
7.442800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.793400E-01 |
| Normal-vs-AfricanAmerican |
5.129400E-01 |
| Normal-vs-Asian |
7.215200E-01 |
| Caucasian-vs-AfricanAmerican |
3.901400E-01 |
| Caucasian-vs-Asian |
9.420200E-01 |
| AfricanAmerican-vs-Asian |
4.183600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.964630E-01 |
| Normal-vs-Female |
9.859600E-01 |
| Male-vs-Female |
1.032760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.480400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.873800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.638600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.002440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.641500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.851200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.536160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.832000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.854000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.037600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.940600E-01 |
| Classical-VS-Follicular |
3.036100E-03 |
| Classical-VS-Other |
2.225000E-01 |
| Classical-VS-Normal |
5.915400E-01 |
| Tall-VS-Follicular |
6.004000E-02 |
| Tall-VS-Other |
1.862020E-01 |
| Tall-VS-Normal |
7.115600E-01 |
| Follicular-VS-Other |
7.965600E-01 |
| Follicular-VS-Normal |
6.026000E-02 |
| Other-VS-Normal |
2.066600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.333400E-01 |
| Normal-vs-N1 |
3.840200E-01 |
| N0-vs-N1 |
9.268400E-01 |
|
|
